The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis-Reference-Cited by-同舟云学术

The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis

Published:2012-04-19 Issue:21 Volume:118 Page:5293-5301
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Chiu Joanne,Tang Yuen Fong,Yao Tzy-Jyun,Wong Ashley,Wong Hilda,Leung Roland,Chan Pierre,Cheung Tan To,Chan Albert C.,Pang Roberta,Fan Sheung-Tat,Poon Ronnie,Yau Thomas

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference18 articles.

1. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial;Cheng;Lancet Oncol.,2009

2. Sorafenib in advanced hepatocellular carcinoma;Llovet;N Engl J Med.,2008

3. Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response;Yau;Cancer.,2009

4. Safety and efficacy of sorafenib in patients with hepatocellular carcinoma (HCC) and Child-Pugh A versus B cirrhosis;Abou-Alfa;Gastrointest Cancer Res.,2011

5. Sorafenib in unresectable hepatocellular carcinoma from mild to advanced stage liver cirrhosis;Pinter;Oncologist.,2009

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Transarterial Chemoembolization Combined with PD-1 Inhibitors plus Molecular Targeted Therapies for Unresectable Hepatocellular Carcinoma with Child‒Pugh B;2024-05-28

2. Updates on Systemic Therapy for Hepatocellular Carcinoma;American Society of Clinical Oncology Educational Book;2024-01

3. Immune Checkpoint Inhibitors for Child-Pugh Class B Advanced Hepatocellular Carcinoma;JAMA Oncology;2023-10-01

4. 2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma;Journal of Liver Cancer;2023-03-31

5. Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma;Therapeutic Advances in Medical Oncology;2023-01